Seeking Alpha

An FDA panel votes unanimously against approval for Regeneron's (REGN -0.1%) Arcalyst, saying...

An FDA panel votes unanimously against approval for Regeneron's (REGN -0.1%) Arcalyst, saying it's unsafe for the treatment of gout flares. (transcript)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)